Evoq Remedies Ltd.
|
HALFYEARLY RESULTS
|
|
You can view the
Halfyearly Results
for the last 5 years.
Market Cap. (Rs.)
|
14.19 Cr.
|
P/BV
|
0.32
|
Book Value (Rs.)
|
17.89
|
52 Week High/Low (Rs.)
|
9/2
|
FV/ML
|
10/4000
|
P/E(X)
|
162.86
|
Bookclosure
|
28/09/2024
|
EPS (Rs.)
|
0.04
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 25.51 | 11.76 | 0.00 | 0.15 | 3.90 |
Total Income From Operations | 25.51 | 11.76 | 0.00 | 0.15 | 3.90 |
Purchase of Traded Goods | 24.93 | 12.18 | 0.00 | 0.82 | 1.83 |
Increase/Decrease in Stocks | 0.23 | 0.91 | 0.00 | -1.57 | 0.47 |
Employees Cost | 0.04 | 0.05 | 0.02 | 0.02 | 0.06 |
Depreciation | 0.03 | 0.04 | 0.00 | 0.00 | 0.00 |
Other Expenses | 1.27 | -0.77 | 1.61 | 2.58 | 1.47 |
Total Expenses | 26.49 | 12.41 | 1.64 | 1.86 | 3.83 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.98 | -0.65 | -1.64 | -1.71 | 0.07 |
Other Income | 1.06 | 2.40 | 0.01 | 2.26 | 0.00 |
P/L Before Interest, Excpt. Items & Tax | 0.08 | 1.75 | -1.62 | 0.54 | 0.07 |
P/L Before Exceptional Items & Tax | 0.08 | 1.75 | -1.62 | 0.54 | 0.07 |
P/L Before Tax | 0.08 | 1.75 | -1.62 | 0.54 | 0.07 |
Tax | 0.02 | 0.04 | 0.00 | 0.15 | 0.02 |
P/L After Tax from Ordinary Activities | 0.05 | 1.71 | -1.62 | 0.39 | 0.05 |
Net Profit/Loss For the Period | 0.05 | 1.71 | -1.62 | 0.39 | 0.05 |
| | | | | |
Equity Share Capital | 24.90 | 24.90 | 24.90 | 13.60 | 13.60 |
Reserves And Surplus | 0.00 | 19.64 | 0.00 | 0.00 | 0.00 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 0.02 | 0.68 | -0.65 | 1.03 | 0.40 |
Diluted EPS (Rs.) | 0.02 | 0.69 | -0.65 | 1.03 | 0.40 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 0.02 | 0.68 | -0.65 | 1.03 | 0.40 |
Diluted EPS (Rs.) | 0.02 | 0.00 | -0.65 | 1.03 | 0.40 |
| | | | | |
PBITOE Margin (%) | -3.85 | -5.54 | N.A | -1143.69 | 1.77 |
PBTE Margin (%) | 0.30 | 14.90 | N.A | 361.64 | 1.77 |
PBT Margin (%) | 0.30 | 14.90 | N.A | 361.64 | 1.77 |
PAT Margin (%) | 0.21 | 14.56 | N.A | 260.24 | 1.28 |